Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 313.01 USD 0.34% Market Closed
Market Cap: 22B USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Insulet Corp

Revenue
2.4B USD
Cost of Revenue
-690.3m USD
Gross Profit
1.7B USD
Operating Expenses
-1.3B USD
Operating Income
407.3m USD
Other Expenses
-171.2m USD
Net Income
236.1m USD

Margins Comparison
Insulet Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Insulet Corp
NASDAQ:PODD
22B USD
71%
17%
10%
US
Abbott Laboratories
NYSE:ABT
215.2B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.5B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
149.1B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
136.2B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
116.3B USD
65%
20%
14%
DE
Siemens Healthineers AG
XETRA:SHL
54.6B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
51.2B USD
45%
14%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.5B USD
62%
31%
24%
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
78%
28%
23%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
257B CNY
59%
28%
26%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Insulet Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Insulet Corp
NASDAQ:PODD
22B USD
19%
7%
17%
16%
US
Abbott Laboratories
NYSE:ABT
215.2B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.5B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
149.1B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
136.2B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
116.3B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
54.6B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
51.2B USD
6%
3%
6%
5%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.5B USD
65%
29%
57%
34%
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
14%
10%
14%
16%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
257B CNY
23%
15%
20%
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less